Praxis fuer Gefaeßmedizin
- Address
- Carolusstraße 214, 02827 Görlitz, Germany
Praxis fuer Gefaeßmedizin - Vascular Medicine Center
Praxis fuer Gefaeßmedizin is a specialized vascular medicine center dedicated to advancing the treatment and prevention of thromboembolic disorders. The center focuses on clinical research in patients with complex vascular conditions, particularly those with cancer-associated complications requiring specialized anticoagulation management.
- Venous thromboembolism (VTE) prevention and treatment in cancer patients
- Novel anticoagulation therapies for gastrointestinal and genitourinary malignancies
- Comparative effectiveness studies of antithrombotic agents
The center participates in pivotal phase 3 multicenter trials evaluating next-generation anticoagulants against standard therapies. Their expertise encompasses the management of cancer-associated thrombosis, a challenging clinical scenario requiring careful balance between preventing VTE recurrence and minimizing bleeding complications in vulnerable patient populations with GI/GU malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Anthos Therapeutics Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis fuer Gefaeßmedizin
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Multicenter Randomized Study of Abelacimab vs. Apixaban on VTE Recurrence and Bleeding in Cancer-Associated Venous Thromboembolism | Anthos Therapeutics Inc. | Phase IV | Not Recruiting | Aug 2022 | Feb 2026 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abelacimab | 2 | Unknown | 2022-08-10 | 2022-09-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.